Arq. Bras. Cardiol. 2020; 115(5): 953-955
Emerging Topics in Heart Failure: Interventional Heart Failure Therapies
João Manoel Rossi Neto
, Dirceu Rodrigues de Almeida
, Fernando Antibas Atik
, Monica Samuel Avila
, Marcely Gimenes Bonatto
Treatment of Secondary Mitral Regurgitation
Before considering percutaneous treatment of mitral regurgitation (MR) for patients with heart failure (HF) with reduced ejection fraction (HFrEF) and severe MR, we recommend that guideline-directed medical therapy be optimized, including cardiac resynchronization therapy and revascularization, where appropriate.
The use of the edge-to-edge device could benefit patients with moderately severe or severe secondary MR (effective regurgitant orifice area [EROA] ≥ 30 mm2 and/or regurgitant volume > 45 mL) with a left ventricular ejection fraction (LVEF) of 20 to 50%, left ventricular (LV) end-systolic diameter < 7.0 cm, and persistent symptoms despite maximized evidence-based medical therapy, with the participation of an experienced multidisciplinary team in the evaluation and treatment of HF and MR.
[…]
636
